Unknown

Dataset Information

Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.


ABSTRACT:

Importance

In patients with severe aortic stenosis (AS) at intermediate surgical risk, treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) results in similar 2-year survival. The effect of TAVR vs SAVR on health status in patients at intermediate surgical risk is unknown.

Objective

To compare health-related quality of life among intermediate-risk patients with severe AS treated with either TAVR or SAVR.

Design, setting, and participants

Between December 2011 and November 2013, 2032 intermediate-risk patients with severe AS were randomized to TAVR with the Sapien XT valve or SAVR in the Placement of Aortic Transcatheter Valve 2 Trial and were followed up for 2 years. Data analysis was conducted between March 1, 2016,

SUBMITTER: Baron SJ 

PROVIDER: S-EPMC5710586 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature